back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-05-20 15:15 Tx date 2022-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,955
+1,735 vol $8.62 each |
3,150 | |
| Filed 2021-09-08 09:38 Tx date 2021-09-07 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,004
+535 vol $18.70 each |
1,415 | |
| Filed 2021-08-13 16:03 Tx date 2021-06-28 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$119.97
+31 vol $3.87 each |
163 | |
| Filed 2021-08-13 15:59 Tx date 2021-06-28 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
-31 vol |
0 | |
| Filed 2021-08-13 15:49 Tx date 2021-06-28 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-158.67
-41 vol $3.87 each |
31 | |
| Filed 2021-07-13 10:52 Tx date 2021-07-01 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-158.67
-41 vol $3.87 each |
||
| Filed 2021-07-13 10:52 Tx date 2021-07-01 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
97 - Other
|
$-158.67
-41 vol $3.87 each |
31 | |
| Filed 2021-06-23 14:06 Tx date 2021-06-22 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,020
+880 vol $22.75 each |
880 | |
| Filed 2021-06-23 14:03 Tx date 2020-11-30 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-26 09:37 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,799
+10,000 vol $22.08 each |
20,000 | |
| Filed 2020-12-16 14:30 Tx date 2020-12-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$230,200
+10,000 vol $23.02 each |
10,000 | |
| Filed 2020-12-16 14:28 Tx date 2020-11-30 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-11 17:44 Tx date 2020-12-07 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,049
+15,000 vol $4.27 each |
121,747 | |
| Filed 2020-06-13 17:52 Tx date 2020-06-08 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$815,480
+58,000 vol $14.06 each |
106,747 | |
| Filed 2020-05-31 12:47 Tx date 2020-05-26 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$114,029
+7,497 vol $15.21 each |
48,747 | |
| Filed 2020-05-31 12:47 Tx date 2020-05-26 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$-202,419
-7,497 vol $27.00 each |
41,250 | |
| Filed 2020-02-16 10:41 Tx date 2020-02-11 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,410.883
-185 vol $13.03 each |
132 | |
| Filed 2020-02-16 10:39 Tx date 2020-02-11 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+296 vol |
317 | |
| Filed 2020-02-16 10:38 Tx date 2020-02-11 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-85,840
-296 vol $290.00 each |
72 | |
| Filed 2020-02-16 10:34 Tx date 2020-02-11 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+21 vol |
21 | |
| Filed 2020-02-16 10:33 Tx date 2018-08-01 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-16 10:33 Tx date 2020-02-11 |
$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-8,190
-21 vol $390.00 each |
368 | |
| Filed 2019-09-06 15:40 Tx date 2019-09-03 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$494,587
+41,250 vol $11.99 each |
48,747 | |
| Filed 2019-09-06 15:38 Tx date 2019-09-03 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-7,489,503 vol |
7,497 | |
| Filed 2019-09-06 12:12 Tx date 2019-09-06 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
37 - Stock split or consolidation
|
-389,011 vol |
389 | |
| Filed 2019-09-04 16:44 Tx date 2019-09-04 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
99 - Correction of information
|
$-12,168
-31,200 vol $0.39 each |
389,400 | |
| Filed 2019-06-21 12:55 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$-39,000
-100,000 vol $0.39 each |
7,497,000 | |
| Filed 2019-06-21 12:54 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
$-38,500
-50,000 vol $0.77 each |
7,597,000 | |
| Filed 2019-06-21 12:48 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,414
+682,000 vol $0.027 each |
7,647,000 | |
| Filed 2019-06-21 12:47 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,005
+6,815,000 vol $0.027 each |
6,965,000 | |
| Filed 2019-02-06 Tx date 2019-02-01 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,782
+295,800 vol $0.29 each |
420,600 | |
| Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$48,672
+124,800 vol $0.39 each |
124,800 | |
| Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$36,504
+93,600 vol $0.39 each |
||
| Filed 2018-12-18 Tx date 2018-12-13 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,000
+100,000 vol $0.39 each |
150,000 | |
| Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$36,504
+93,600 vol $0.39 each |
93,600 | |
| Filed 2018-12-07 Tx date 2018-08-01 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,500
+50,000 vol $0.77 each |
50,000 | |
| Filed 2018-12-07 Tx date 2018-08-01 |
$PLI
Prometic Life Sciences Inc. |
Lortie, Murielle
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-07 Tx date 2016-06-01 |
$BLU
BELLUS Health Inc. |
Lortie, Murielle
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pharmascience Inc. (Control or Direction)
|
Units of BHI Limited Partnership
36 - Conversion or exchange
|
-104 vol |
0 | |
| Filed 2016-06-07 Tx date 2015-02-24 |
$BLU
BELLUS Health Inc. |
Lortie, Murielle
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pharmascience Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-07 Tx date 2016-06-01 |
$BLU
BELLUS Health Inc. |
Lortie, Murielle
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pharmascience Inc. (Control or Direction)
|
Common Shares
36 - Conversion or exchange
|
+6,350,638 vol |
6,350,638 |